暂无简介。

入排标准

•1)other active disease 2)pregnancy 3)previous administration of GEM 4)active bleeding or hematological disorders 5)HBV,HCV,HIV carriers 6)active infection 7)progressive brain, meningeal or bone metastasis 8)autoimmnune disorders 9)drug allergies 10)During treatment with immunosuppressive agents 11)interstitial pneumonia 12)Severe psychiatric disease 13)Patients whom doctors judged inadequate to the enrollment of this study by other reasons

Phase I study of Wilms' tumor gene WT1 peptide vaccination combined with gemcitabine for patients with advanced non-small-cell lung cancer - Phase I study of Wilms' tumor gene WT1 peptide vaccination combined with gemcitabine for patients with advanced non-small-cell lung cancer

试验速览